EyeCon 2026 Banner
Opinion|Videos|June 1, 2026

Advancing Care Across Retinal Vascular Diseases

Welcome back to another Ophthalmology Times series. In this episode titled, “Advancing Care Across Retinal Vascular Diseases,” the expert faculty discussed the evolving management of retinal vascular diseases, including age-related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR), and retinal vein occlusion (RVO). The panel reviewed the significant prevalence and treatment burden associated with these chronic retinal conditions, emphasizing how frequently these diseases are encountered in clinical retina practice and the challenges associated with maintaining long-term patient adherence to therapy.

Welcome back to another Ophthalmology Times series. In this episode titled, “Advancing Care Across Retinal Vascular Diseases,” the expert faculty discussed the evolving management of retinal vascular diseases, including age-related macular degeneration (AMD), diabetic macular edema (DME), diabetic retinopathy (DR), and retinal vein occlusion (RVO). The panel reviewed the significant prevalence and treatment burden associated with these chronic retinal conditions, emphasizing how frequently these diseases are encountered in clinical retina practice and the challenges associated with maintaining long-term patient adherence to therapy.

Throughout the discussion, the panelists highlighted how disease prevalence and patient populations can vary across different practice settings, with some clinics seeing a greater proportion of AMD while others manage more diabetic eye disease. The expert faculty also emphasized the growing burden associated with aging populations and increasing numbers of patients requiring ongoing anti-VEGF therapy and routine monitoring. In addition, the panel discussed the importance of maintaining patient engagement and adherence, noting that consistent follow-up and regular treatment are critical to achieving optimal long-term visual outcomes.

The panel also explored how the expanding therapeutic landscape continues to shape retinal disease management, with newer treatment modalities and evolving anti-VEGF strategies increasing both opportunities and complexities in clinical care. Collectively, the discussion underscored the substantial clinical and operational burden retinal vascular diseases place on retina specialists and highlighted the need for durable, flexible treatment approaches that support long-term disease control.

In the next episode, “Diagnostic Imaging in Retinal Vascular Disease Management,” the panelists will continue their discussion on retinal vascular diseases and highlight the expanding role of multimodal imaging in clinical practice. The expert faculty will discuss advancements in optical coherence tomography (OCT) , OCT angiography, and ultra-widefield imaging, as well as how these technologies are improving early detection, disease monitoring, and individualized patient management across AMD, DME, DR, and RVO.


Latest CME